Neuren Pharmaceuticals Ltd. (NEU.AX), a company that developes new therapies for brain injury, cancer etc., Friday announced that Joseph Horrigan has joined the company as the Vice President of clinical development and medical affairs.
Horrigan recently worked at Autism Speaks as Assistant Vice President and Head of Medical Research. In that role, he oversaw the organization's medical research and training programs including consulting with academic and industry groups on clinical trial design and endpoints in neurodevelopmental disorders.
From 2002 until he joined Autism Speaks, Horrigan coordinated paediatric drug development in the Neurosciences Medicines Development Center at GlaxoSmithKline.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.